Allergan has said it is not interested in buying Shire after all, after announcing yesterday that it was considering a bid for the UK-listed firm also targeted by Takeda.
Takeda has raised eyebrows after announcing its intention to bid for UK pharma Shire, with analysts suggesting the Japanese pharma will have to overpay to clinch the deal.
